Ameritas Investment Partners’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-918
Closed -$6.84K 3110
2023
Q1
$6.84K Hold
918
﹤0.01% 2814
2022
Q4
$10.6K Hold
918
﹤0.01% 2787
2022
Q3
$18K Hold
918
﹤0.01% 2564
2022
Q2
$25K Hold
918
﹤0.01% 2426
2022
Q1
$40K Hold
918
﹤0.01% 2184
2021
Q4
$51K Hold
918
﹤0.01% 2110
2021
Q3
$57K Hold
918
﹤0.01% 2065
2021
Q2
$78K Hold
918
﹤0.01% 1882
2021
Q1
$73K Buy
918
+218
+31% +$14.2K ﹤0.01% 1848
2020
Q4
$41K Buy
700
+169
+32% +$7.96K ﹤0.01% 2087
2020
Q3
$18K Hold
531
﹤0.01% 2421
2020
Q2
$25K Hold
531
﹤0.01% 2226
2020
Q1
$8K Hold
531
﹤0.01% 2627
2019
Q4
$15K Hold
531
﹤0.01% 2538
2019
Q3
$16K Hold
531
﹤0.01% 2500
2019
Q2
$15K Buy
+531
New +$17.9K ﹤0.01% 2603

Other funds holding AFMD

Ameritas Investment Partners's AFMD Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Affimed (AFMD) in Q2 2023, closing a stake of 918 shares — an estimated $6.84K sold.

Ameritas Investment Partners first reported a position in AFMD in Q2 2019 and held it in 16 quarters. The position peaked at $78K in Q2 2021. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • Ameritas Investment Partners reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 918 Affimed shares in Q2 2023, an estimated $6.84K.
  • Ameritas Investment Partners first reported a position in Affimed in Q2 2019 and held it in 16 quarters.
  • Ameritas Investment Partners's Affimed position peaked at $78K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.